• Feedback
  • RSS Feed
  • Sitemap
Ommcom News
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
Odisha News, Odisha Breaking News, Odisha Latest News || Ommcom News
Home Nation

‘Decide Within 3 Months’: Delhi HC Tells CDSCO On Plea Against Use Of Diabetes Drugs In Weight Management

OMMCOM NEWS by OMMCOM NEWS
July 2, 2025
in Nation
Diabetes Drugs

New Delhi: The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months, a representation raising safety concerns on the usage of GLP-1-RA drugs in weight management and aesthetic treatment.

A bench of Chief Justice Devendra Upadhyaya and Justice Tushar Rao Gedela was hearing a public interest litigation (PIL) against the manner in which Glucagon Like Peptide -1 Receptor Agonist (RA) (GLP-1-RA) drugs, specifically semaglutide, tirzepatide, and liraglutide have been granted marketing approval in India for weight loss and aesthetic purposes, despite being originally approved for treatment of Type 2 diabetes.

The PIL, filed through advocate Rohit Kumar, referred to the significant risks posed by these medications, including pancreatitis, gastrointestinal damage, thyroid and pancreatic cancers, cardiovascular complications, metabolic dysregulation, and optic neuropathy.

In its order, the CJ Upadhyaya-led Bench directed the PIL litigant to submit to CDSCO the scientific studies and data relied upon in the petition.

Asking the CDSCO to decide the representation within 3 months, the Delhi High Court closed the proceedings and disposed of the matter.

As per the petition, GLP-1-RA drugs were originally developed and internationally approved for the treatment of Type 2 Diabetes Mellitus, but over the past few years, have been “repurposed and approved often through accelerated pathways for obesity treatment and chronic weight management, based largely on short-term efficacy trials”.

Questioning the CDSCO’s grant of marketing approval of these drugs for weight loss purposes in the country, the plea cited limited safety data, lack of India-specific clinical trials, and absence of a robust pharmacovigilance or regulatory oversight mechanism.

It said that there is no evidence to suggest that these drugs have undergone rigorous safety evaluation within the Indian population and highlighted the “aggressive” and “unregulated marketing” of these drugs for aesthetic and non-medical purposes.

“Pharmaceutical companies, clinics, and digital wellness platforms are promoting semaglutide and tirzepatide as ‘quick-fix’ weight loss solutions, especially targeting younger populations, including teenagers. The increasing normalisation of these drugs in aesthetic medicine is alarming,” added the PIL.

Further, it said that the lack of transparency surrounding the clinical data submitted for approval of these drugs, the absence of publicly available safety profiles, and the regulatory silence on their off-label use violated the right to health, which encompasses the right to safe medication, informed decision-making, and access to scientific information.

(IANS)

Tags: Delhi HCDiabetesDiabetes DrugsDrugsNew Delhi
ShareTweetSendSharePinShareSend
Previous Post

K’taka Govt Moves HC Against CAT Order Quashing IPS Officer’s Suspension In Stampede Case

Next Post

RJD MLA Ritlal Yadav’s Wife Alleges Threat To His Life In Bhagalpur Jail

Related Posts

India, New Zealand
Nation

India, New Zealand Conclude 2nd Round Of Free Trade Agreement Negotiations

July 25, 2025
Heavy Rains
Nation

Alert In Coastal Andhra Pradesh In View Of Heavy Rains

July 25, 2025
Union Health Minister JP Nadda
Nation

Sudden Deaths Caused By Health Issues, Genetic Link Not Covid Vax: Nadda

July 25, 2025
Major Arms And Fake Currency Cartel Busted
Nation

Delhi: Major Arms And Fake Currency Cartel Busted; Kingpin, Woman Trafficker Among 5 Held

July 25, 2025
ECI
Nation

99.8 Per Cent Bihar Electors Covered Under SIR: ECI

July 25, 2025
Kiren Rijiju
Nation

Unanimity On 16-Hour Discussion On Operation Sindoor In LS On July 28: Kiren Rijiju

July 25, 2025
Next Post
RJD MLA Ritlal Yadav

RJD MLA Ritlal Yadav's Wife Alleges Threat To His Life In Bhagalpur Jail

Opposition

Farmers' Suicides: Oppn Walks Out Twice From Assembly, Accuses Maha Govt Of Apathy

Starlink

Elon Musk’s Starlink Launches Satellite Internet Services In Sri Lanka, Nearing India Entry

khimji
TPCODL
OMC
  • Feedback
  • RSS Feed
  • Sitemap

© 2025 - Ommcom News. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

© 2025 - Ommcom News. All Rights Reserved.